YAZ LAWSUIT SETTLEMENTS UPDATE JULY 2012:
On July 31, 2012, BLOOMBERG reported that BAYER has agreed to settle 1,877 YAZ LAWSUITS or YAZ CLAIMS involving blood clots for $402 Million U.S. Dollars. This report is a follow up to prior reports confirming that the manufactured of DROSPIRENONE (DRSP) containing birth control pills was settling portions of nearly 13,000 pending lawsuits over the controversial family of contraceptives that has grown to include the trademarked YASMIN, YAZ, BEYAZ, SAFYRAL and generic equivalents OCELLA and GIANVI.
On April 26, 2012, BLOOMBERG reported that BAYER, the manufacturer of trademarked birth control pills containing DRSP (DROSPIRENONE) had agreed to pay $142 Million U.S. Dollars to victims of blood clots that used their pills prior to the April 10, 2012, label change. The BLOOMBERG story, entitled “BAYER YASMIN LAWSUITS CLIMB TO $142 MILLION” was reported by Jef Feeley & Margaret Cronin Fisk. The U.S. Food & Drug Administration (FDA) announced, earlier, on April 10th, that the pills would carry an updated warning, informing consumers and prescribers, that the pills may be linked to 3x higher risk of blood clots than other pills. An FDA funded study had found this risk was 74% higher in comparison to other hormonal contraceptives. Since August 2009, multiple studies have reached similar conclusions.
On April 13, 2012, BLOOMBERG reported on the manufacturer of DRSP (DROSPIRENONE) containing birth control pills, BAYER, having agreed to pay at least $100 MILLION U.S. Dollars to settle a select group of 500 blood clot cases involving the YASMIN/YAZ family of contraceptives. This settlement is discussed here.
Previously, on January 5, 2012, BLOOMBERG publicly reported that “BAYER JUDGE POSTPONES FIRST YAZ TRIAL, ORDERS BIRTH-CONTROL CASES MEDIATED“, in a story by J. Feely & N. Kresge. This confirms that YAZ LAWSUITS may be reaching, or relevant parties, may be attempting to reach YAZ SETTLEMENTS in 2012 following YAZ MEDIATIONS. The first “Bellwether” cases were scheduled to commence Trials, before civil juries, on January 9, 2012. Only a month earlier, on December 8, 2011, the FDA Advisory Committee considered mounting evidence of increased blood clot risk from the DROSPIRENONE (DRSP) containing family of birth control pills. FDA’s recent review is expected to result in new warnings – which have been ‘evolving warnings’ – on the pills confirming an elevated risk of blood clots that was not previously disclosed, or was in fact disputed by BAYER, for years prior to the hearings and FDA’s own funded study confirmed a higher risk.
As reported in “BAYER JUDGE POSTPONES FIRST YAZ TRIAL, ORDERS BIRTH-CONTROL CASES MEDIATED“, the parties have been sent to discuss potential YAZ SETTLEMENTS with a skilled Mediator, or third party with an expertise in dispute resolution, that has earned a reputation for resolving similar disputes. FDA is expected to follow up on recommendations regarding the pills and their future. Based upon FDA’s own data, the pills have been confirmed as presenting a higher risk of blood clots than other pills and should not arguably be considered the first choice of birth control by most consumers or first time users. How this will be communicated to girls, women, prescribers and the public remains subject to FDA action.
Published reports estimate over 12,000 YAZ LAWSUITS pending throughout the United States as of April 2012. As a result, a select number of cases, referred to as Bellwether cases, were scheduled for Civil Jury Trials during 2012. Trials will ultimately lead to a decision by a jury – known as a verdict – and potentially to settlements of related cases, or YAZ SETTLEMENTS. As of this time, there is no settlement of YAZ LAWSUITS, or any formal YAZ SETTLEMENT that applies to all pending cases.
Anyone that believes they suffered an injury from taking YAZ, or any other DRSP (DROSPIRENONE) containing birth control pills only has a fixed amount of time within which to file a lawsuit or seek legal remedies. This period of time is commonly known as a Statute of Limitations period and varies from State to State. As a result, any woman, or girl, that believes she was injured while taking YAZ, or a DRSP (DROSPIRENONE) containing birth control pill, is encouraged to have her potential claim, or lawsuit, evaluated. Even if the anticipated period of time has passed, given the fact the warning labels on these pills has continually ‘evolved’, a case by case factual evaluation of the potential claim is worthwhile.
Women or girls seeking a FREE CASE EVALUATION of their potential YAZ LAWSUIT, or who wish to seek a legal remedy that could lead to a YAZ SETTLEMENT or inclusiong in future YAZ MEDIATIONS, can use the contact form below to be placed in contact with YAZ ATTORNEYS.